Tension-type headache: An update on mechanisms and treatment

Current Opinion in Neurology

Volumn 13, Issue 3, 2000, Pages 285-289

  Jensen, Rigmor ^a   Olesen, Jes ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BOTULINUM TOXIN; IBUPROFEN; KETOROLAC; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT;

GASTROINTESTINAL SYMPTOM; HUMAN; REVIEW; TENSION HEADACHE;

ANALGESICS; HUMANS; TENSION-TYPE HEADACHE;

EID: 0034130144     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200006000-00009     Document Type: Review

References (57)

1. 1 Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44:1147-1157.
2. 2 Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998; 279:381-383. A large and very well conducted epidemiological survey.
3. 3 Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993; 53:65-72.
4. 4 Ulrich V, Russel MB, Jensen R, Olesen J. A comparison of tension-type headache in migraineurs and in non-migraineurs: a population-based study. Pain 1996; 67:501-506.
5. 5 Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(Suppl. 7):196.
6. 6 Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 1991; 46:125-132.
7. 7 Schoenen J, Gerard P, De Pasqua V, Sianard-Gainko J. Multiple clinical and paraclinical analyses of chronic tension-type headache associated or unassociated with disorder of pericranial muscles. Cephalalgia 1991; 11:135-139.
8. 8 Jensen R. Pathophysiological mechanisms of tension-type headache. A review of epidemiological and experimental studies. Cephalalgia 1999; 19:602-621. An extensive discussion of the possible pathophysiological mechanisms based on eight epidemiological and clinical studies and a review of the literature.
9. 9 Langemark M, Olesen J. Pericranial tenderness in tension headache. Cephalalgia 1987; 7:249-255.
10. 10 Jensen R, Rasmussen BK, Pedersen B, Olesen J. Muscle tenderness and pressure pain thresholds in headache. A population study. Pain 1993; 52:193-199.
11. 11 Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996; 53:373-376.
12. 12 Schoenen J, Bottin D, Hardy F, Gerard P. Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache. Pain 1991; 47:145-149.
13. 13 Langemark M, Jensen K, Jensen TS, Olesen J. Pressure pain thresholds and thermal nociceptive thresholds in chronic tension-type headache. Pain 1989; 38:203-210.
14. 14 Sakai F, Ebihara S, Akiyama M, Horikawa M. Pericranial muscle hardness in tension-type headache. A non-invasive measurement method and its clinical application. Brain 1995; 118:523-531.
15. 15 Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Measurement of muscle hardness: a methodological study. Cephalalgia 1998; 18:106-111.
16. 16 Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain 1999; 79:201-205.
17. 17 Bendtsen L, Jensen R, Olesen J. Qualitatively altered nociception in chronic myofascial pain. Pain 1996; 65:259-264.
18. 18 Schoenen J, Jamart B, Gerard P, Lenarduzzi P, Delwaide PJ. Exteroceptive suppression of temporalis muscle activity in chronic headache. Neurology 1987; 37:1834-1836.
19. 19 Wang W, Schoenen J. Reduction of temporalis exteroceptive suppression by peripheral electrical stimulation in migraine and tension-type headaches. Pain 1994; 59:327-334.
20. 20 Zwart JA, Sand T. Exteroceptive suppression of temporalis muscle activity: a blind study of tension-type headache, migraine and cervicogenic headache. Headache 1995; 35:338-343.
21. 21 Bendtsen L, Jensen R, Brennum J, Arendt-Nielsen L, Olesen J. Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state. Cephalalgia 1996; 16:251-256.
22. 22 Langemark M, Bach FW, Jensen TS, Olesen J. Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch Neurol 1993; 50:1061-1064.
23. 23 Bach F, Langemark M, Secher NH, Olesen J. Plasma and cerebrospinal fluid β-endorphin in chronic tension-type headache. Pain 1992; 51:163-168.
24. 24 Ashina M, Bendtsen L, Jensen R, Ekman R, Olesen J. Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache. Pain 1999; 83:541-547.
25. 25 Langemark M, Bach FW, Ekman R, Olesen J. Increased cerebrospinal fluid met-enkephalin immunoreactivity in patients with chronic tension-type headache. Pain 1995; 63:103-107.
26. 26 Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999; 353:287-289. A very interesting and completely new principle in headache treatment. The treatment is not clinically relevant but can pave the way in the future for more specific and long-lasting NO synthase inhibitors, and most importantly can provide important information about the underlying pathophysiology.
27. 27 Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain 1999; 122:1629-1635. Several psychophysical tests are studied during the treatment with NO synthase inhibition.
28. 28 Goadsby PJ. Chronic tension-type headache: where are we? Brain 1999; 122:1611-1612. A critical comment on the new aspects and progress in tension-type headache.
29. 29 Holroyd KA, France JL, Nash JM, Hursey KG. Pain state as artifact in the psychological assessment of recurrent headache sufferers. Pain 1993; 53:229-235.
30. 30 Rasmussen BK. Migraine and tension-type headache in a general population: psychosocial factors. Int J Epidemiol 1992; 21:1138-1143.
31. 31 Mitsikostas DD, Thomas AM. Comorbidity of headache and depressive disorders. Cephalalgia 1999; 19:211-217. A large and well-conducted study of depressive disorders in migraineurs, subjects with tension-type headache and drug abusers presenting very different prevalences of depression according to the headache diagnosis.
32. 32 Rasmussen BK, Jensen R, Olesen J. Interrelations between migraine and tension-type headache in the general population. Arch Neurol 1992; 49:914-918.
33. 33 Rasmussen BK. Migraine and tension-type headache are separate disorders. Cephalalgia 1996; 16:217-220.
34. 34 Östergaard S, Russell MB, Bendtsen L, Olesen J. Increased familial risk of chronic tension-type headache. BMJ 1997; 314:1092-1093.
35. 35 Russell MB, Ostergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia 1999; 19:207-210.
36. 36 Jensen R, Bendtsen L, Olesen J. Muscular factors are of importance in tension-type headache. Headache 1998; 38:10-17.
37. 37 Mathew N, Schoenen J. Acute pharmacotherapy of tension-type headache. In: The headaches, 2nd ed. Olesen J, Tfelt-Hansen P, Welch KMA (editors). Philadelphia: Lippincott Williams and Wilkins; 2000. pp. 661-666. A complementary, and interesting review of numerous treatment studies through past decades.
38. 38 Mathew N, Bendtsen L. Prophylactic pharmacotherapy of tension-type headache. In: The headaches, 2nd ed. Olesen J, Tfelt-Hansen P, Welch KMA (editors). Philadelphia: Lippincott Williams and Wilkins; 2000. pp. 667-673. A complementary, high quality review of numerous treatment studies through past decades.
39. 39 International Headache Society-Committee on Clinical Trials. Guidelines of drug treatments in tension-type headache. Cephalalgia 1995; 15:165-179.
40. 40 Peters BH, Fraim CJ, Masel BE. Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other and with placebo in moderately severe headache. Am J Med 1983; 74:36-42.
41. 41 Dahlhöf CGH, Jacobs LD. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia 1998; 16:117-123.
42. 42 Steiner TJ, Lange R. Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia 1998; 18:38-43. A very systematic treatment study in which sound methodology is applied.
43. 43 Van Gerven JMA, Schoemaker RC, Jacobs LD, Reints A, Ouwersloot-van der Meij MJ, Hoedemaker HGH. Self medication of a single episode of tension-type headache with ketoprofen, ibuprofen and placebo, home-monitored with an electronic patient diary. Br J Clin Pharmacol 1996; 42:475-481.
44. 44 Harden RN, Rogers D, Fink K, Gracely RH. Controlled trial of ketorolac in tension-type headache. Neurology 1998; 50:507-509.
45. 45 Hammill JM, Cook TM, Rosecrane JC. Effectiveness of a physical therapy regimen in the treatment of tension-type headache. Headache 1996; 36:149-153.
46. 46 Jensen R, Olesen J. Is there an effect of physiotherapy in tension-type headache? Cephalalgia 1995; 15:152.
47. 47 Bove G, Nielsson N. Spinal manipulation in the treatment of episodic tension-type headache. A randomized controlled trial. JAMA 1998; 280:1576-1579. A well conducted, controlled treatment trial comparing conventional physical therapy with spinal manipulation, with negative results.
48. 48 Marcus AM. Spinal manipulation for tension-type headache. JAMA 1999; 282:232-233.
49. 49 Vemon H, McDermaid CS, Hagino C. Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache. Compl Therap Med 1999; 7:142-155. A very necessary review and attempt to validate the numerous alternative therapies offered to patients.
50. 50 Bendtsen L, Jensen R, Olesen J. A non selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol, Neurosurg, Psychiatry 1996; 61:285-290.
51. 51 Oguzhanoglu A, SahinerT, Kurt T, Akalin O. Use of amitriptyline and fluoxetine in the prophylaxis of migraine and tension-type headaches. Cephalalgia 1999; 19:531-532. An open-labelled, uncontrolled study comparing two active drugs in 17 migraineurs, 19 patients with episodic and 13 with chronic tension-type headache.
52. 52 Cerbo R, Barbananti P, Fabbrini G, Pascall MP, Catarci T. Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenic implications. Headache 1998; 38:453-457. A well-conducted, controlled study with an interesting hypothesis and discussion part.
53. 53 Cohen GL. Protriptyline, chronic tension-type headaches, and weight loss in women. Headache 1997; 37:433-436.
54. 54 Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Res 1999; 26:183-186.
55. 55 Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998; 38:468-471.
56. 56 Relja M, Korsic M. Treatment of tension-type headache by injections of botulinum toxin type A: double-blind placebo controlled study. Neurology 1999; 52:A203.
57. 57 Smuts JA, Baker MK, Smuth HM, Stassen JMM, Rossouw E. Botulinum toxin type A as prophylactic treatment in chronic tension-type headache. Cephalalgia 1999; 19:454.